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ABSTRACT: We performed flow cytometry and cytogenetic analysis of 37 adenocarcinomas of the dis- 
tal esophagus and cardia, of which 22 arose in Barrett's mucosa. Two of eight analyzed specimens of 
Barrett's mucosa bad clonal chromosomal bnormalities. In 19 cases clonal chromosomal bnormali- 
ties were found in tumor tissue. The complex pattern of cytogenetic changes did not differ among the 
adenocarcinomas risen in Barrett's esophagus, and those in the distal esophagus without Barrett's 
mucosa or cardia. Abnormal karyotypes with multiple and complex rearrangements were seen in 11 
cases and with single or a few numeric hanges in eight. Losses of chromosomes 4, 18, 21, and Y were 
the most frequent numeric changes. Loss of the Y chromosome was observed in eight of 26 tumors of 
males (31%). Gains of chromosomes 14 and 20 were also frequent numeric changes. Structural abnor- 
malities were observed in 13 of the abnormal karyotypes (68%). The chromosome arms most frequently 
rearranged were 10, 3q, 1 l p and 22p. The chromosome arm most frequently contributing to losses was 
lp, with the shortest region of overlap being lp22-33. The chromosome arms most often involved in 
gains were 11p and 22p, and i(3q) was the isochromosome that was most frequently identified. 
INTRODUCTION 
There has been a striking increase in the incidence of ade- 
nocarcinoma of the esophagus and the esophagogastric 
junction in North America and Western Europe in recent 
years [1, 2]. Most esophageal nd gastroesophageal adeno- 
carcinomas appear to arise from Barrett's esophagus [3]. 
As a consequence ofpersistent damage, the squamous epi- 
thelial lining of the esophagus is replaced by columnar 
epithelium. The risk of developing an adenocarcinoma in 
Barrett's esophagus i at least 30-125 times that expected 
for a similar population without Barrett's esophagus [4]. 
Barrett's adenocarcinoma occurs as a result of progression 
of severe dysplastic hanges in the abnormal mucosal lin- 
ing of the esophagus, involving a series of genetic alter- 
ations in the cells that comprise the Barrett's epithelium 
[5]. A better understanding of the underlying mechanisms 
of carcinogenesis in Barrett's esophagus and the discovery 
of markers identifying the subset of patients at high risk 
would be of great importance. The correlation between 
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dysplastic hanges and aneuploidy has been demonstrated 
by flow cytometric (FCM) techniques [5, 6]. A few studies 
demonstrated clonal chromosome abnormalities in Bar- 
rett's epithelium and adenocarcinoma [7-10]. The karyo- 
types were often complex, but loss of the Y chromosome 
was a frequent finding. Genetic changes affecting 3q and 
the 11p13-15 region have been described in esophageal 
adenocarcinomas s well as in gastric cancer [8, 9]. How- 
ever, since the cytogenetic study of solid tumors and pre- 
malignant issues is difficult, there are no large series 
reported. 
We report cytogenetic studies of 37 adenocarcinomas of 
the distal esophagus and cardia of which the majority 
(59%) arose in Barrett's mucosa. In these cases (n = 22} 
cytogenetic analysis was also performed on Barrett's epi- 
thelium. 
MATERIALS AND METHODS 
Patients 
Patients with an esophageal carcinoma were referred to 
the Rotterdam Esophageal Tumor Study Group for evalua- 
tion and treatment. Three groups were investigated: 1) 
patients with an adenocarcinoma in Barrett's esophagus; 
2) patients with an adenocarcinoma in the distal esopha- 
gus without Barrett's mucosa; and 3} patients with an ade- 
nocarcinoma of the cardia. All patients underwent an 
esophagectomy without preoperative radiotherapy or che- 
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motherapy, and were included in the study during the Table 1 
period November 1989 to August 1992. Tissue specimens 
of 37 patients (26 male and 11 female; mean age of 62 
years) were analyzed by histopathologic, FCM, and cyto- 
genetic methods. 
Patient 
Pathology no. Sex Age 
Based on histopathologic findings and site of the tumor, 1 F 
the 37 adenocarcinomas of the patients were divided into 3 M 
three subgroups: 5 M 
9 M 
1. Adenocarcinoma in Barrett's esophagus, if the bulk 11 M 
of the tumor was located in the distal esophagus and 12 F 
columnar epithelium was found proximal to the 13 M 
tumor at microscopic examination (  = 22). 17 M 
2. Adenocarcinoma in the distal esophagus, if the bulk 18 M 
of the tumor was located in the distal esophagus and 19 M 
no columnar epithelium could be demonstrated 20 F 
23 F 
proximal to the tumor by microscopic examination 24 F 
(n = lo). 25 F 
3. Adenocarcinoma of the cardia, if the bulk of the 26 F 
tumor was located in the cardia with tumor growth 27 M 
into the distal esophagus (n = 5). 29 M 
31 M 
From all 37 resect ion  spec imens  fresh t issue samples  of 32 F 
the esophageal  mucosa  and  the tumor  were taken out  and  36 F 
d iv ided  into three parts, One part  of every t issue sample  38 M 
was used  for h i s topatho log ic  analysis ,  one for cytogenet ic  39 M 
analysis ,  and  a th i rd  part  was stored in l iqu id  n i t rogen 
( -70°C)  for FCM. In a few cases t issue samples  were taken 
from lymph node  metastases.  
If co lumnar  ep i the l ium was found,  spec imens  were 
des ignated as no  dysplas ia,  mi ld- ,  moderate- ,  and  severe 
dysp las ia  accord ing to cr i ter ia for ep i the l ia l  dysp las ia  in 
the s tomach as descr ibed  by Morson  et al. [11]. In all tu- 
mor  spec imens  adenocarc inoma was found and  the differ- 
ent ia t ion  grade of the tumor  was determined .  
Clinical and histopathologic characteristics of 22 
patients with an adenocarcinoma in Barrett's 
esophagus 
Mucosa 
Aden°carcin°ma'~ Grade of 
pTNM Grade b Type ~: dysplasia 
76 T3NIM0 G1 
61 TINOM0 G3 
58 T3NIM0 G2 Squamous 
45 T2NOM0 G3 Barrett Mild 
63 TINOM0 G3 Barrett Mild 
65 T3NIM0 G3 
59 T3N1M0 G3 Squamous 
80 TINOM0 G2 Barrett Moderate 
67 T3NIM0 G3 
69 T3NIM0 G3 d Barrett No 
67 T3NIM1 G3 Barrett Moderate 
77 T3NOM0 G2 Barrett No 
68 T1NOMO G2 Barrett Severe 
75 TINOM0 G2 Barrett Mild 
67 T3NIM1 G3 
77 T3NIM0 G3 Barrett No 
70 T2NOM0 G2 Barrett Mild 
53 T3NIM0 G2 Squamous 
64 T2NOM0 G1 Barrett No 
73 T3NIM1 G2 Barrett Moderate 
50 T3NIMO G3 
7O T3NOM0 G3 
"Histopathologic diagnosis of tissue samples for flow cytometric and cyto- 
genetic analysis. 
bDifferentiation grade: G1 - well differentiated; G2 = moderately differen- 
tiated; G3 = poorly differentiated. 
'Histologic diagnosis of mucosa specimens on which cytogenetic and flow 
cytometric analysis were performed. 
aTissue sample from a lymph node metastasis. 
Table 2 Flow cytometric and cytogenetic analysis of Barrett's mucosa 
Patient Flowcytometry 
no. (DNA indices) Total Normal 
Number of metaphases analyzed 
Abnormal Abnormal 
nonclonal clonal Karyotype of clonal abnormality 
9 Aneuploid (1.93, 3.43) 
11 Diploid 1 1 
17 Diploid 16 7 4 
19 Diploid 26 2O 6 
20 Tetraploid 6 4 2 
23 Diploid 2 2 
24 Aneuploid (1.18, 2.32) 3 2 1 
25 Aneuploid (1.61) 5 
27 Diploid 
29 Diploid 
32 Diploid 
36 Diploid 
1 1 
5 45(34-46),X,-Y[cp5] 
1 +4 a 72<3n>,XXX,+ 3 , -4 , -  5 , -  5 , -  6,+ 8,+add(9)(p22),+ del
(10)(q23),- 11,+ 12,-  14,add(15)(p12),+add(15)(q21), 
add (17)(p12),- 18,+add(19)(q13),+ 20,-  21,+ 22, 
+marl ,  +mar2[cp4] 
"Indicates metaphases that were counted, with markers identified, but which could not be completely karyotype& 
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FCM 
Fresh tissue samples for FCM were immediately deep-fro- 
zen and stored in liquid nitrogen (-70°). These specimens 
were prepared for FCM according to the method described 
in Vindelov et al. [12]. The nuclear suspension was fil- 
tered through a 40-~m mesh filter and stained with pro- 
pidium iodide (Sigma Chemical Co., St. Louis, Me). 
Cellular DNA content of at least 10,000 cells was mea- 
sured on FACS scan (Beckton Dickinson, Mountain View, 
CA). The data were fed into a Data General computer. Aneu- 
ploidy was determined both by visual inspection of the 
histograms and confirmation of an aneuploid population 
Table 3 Flowcytometric and cytogenetic analysis of adenocarcinoma in Barrett's esophagus 
Patient Flowcytometry 
no. (DNA indices) Total Normal 
No. of metaphases analyzed 
Abnormal Abnormal 
nonclonal clonal Karyotype of clonal abnormality 
1 10 6 + 4 ~ 
3 1 1 
5 14 9 
9 Aneuploid (1.85, 3.29) 9 6 
11 Tetraploid 6 4 
12 Aneuploid (1.65) 20 16 
13 Diploid 28 3 
17 Anenploid (1.56) 34 12 
18 Aneuploid (1.49) 37 17 
19 Aneuploid (1.50, 2.05) 11 5 2 
20 Diploid 8 6 2 
23 Aneuploid (1.98, 2.93) 12 9 3 
24 Aneuploid (1.20, :2.43) 6 4 2 
25 Aneuploid (1.61) 6 
26 Aneuploid (1.47, 1.78) 4 4 
27 Aneuploid (1.49, 2.07) 
29 Aneuploid (1.69) 8 6 2 
31 Aneuploid (1.42) 7 1 2 
2 1+2 a 
6 16 
2 18 
2 
8+7"  
7+3 ° 
4+2 a 
2+2 ~, 
32 Anenploid (1.99, 2.79) 3 2 1 
36 Anenploid (1.72) 8 5 + 3 ° 
38 1 1 
39 23 10 8 5 
39-42<2n>,X, -X ,+ 3,-4,add(10)(q26),+hsr(11) 
(p14),- 13,-  17,-  18,-  20,-21,add(22)(p11),+mar,+ 
dmin[cplO] 
80<4n>,XXX,-Y,-Y,del(1)(p21p34),+ add(1)(p22),+ 
inv(2)(q13q33),- 3 , -  4 , -  5 , -  6,del(7)(q31),- 7 , -  9 , -  9 
, -  10,-  10,-  10,+ 11,add(12)Cp12),i(13)(qlO), 
-13 , -13 , -13 , -14  add(15)(q26)x2,add(18)(p11), 
- 18,-18,-21,-21,-21,add(22)(p12)x2,+r,  
+marlx2,+mar2, +mar 3 
46-47,XX, + 2mar[cp2] 
37-42<2n>,X,i(Y)(q10),del(1)(p21p34),+ add(3)(q27), 
- 5,i(7)(p10),add(8)(q24),- 9 , -  11,-  12,-  13 i(13) 
(qlO),- 15,-  19,-  20,-  22,add(22)(q13),+r,+mar 
[cp15] 
69(64-83)<3n>,XX,i(Y)(q10),+ 2,+ 3,+ add(3)(q27), 
+4, -  5,+add(6)(q26)x2,i(7)(p10),+i(7)(p10),add(8) 
(q24)x2,- 10,-  11,-  12,i(13)(q10)x2,+ 14,+ 15,-  17, 
- 18,-  19,-  20,+ 21,add(22)(q13]x2,+rx2,+mar 
[cplO] 
45(34-45),X,-Y[10],- 10,-  14,-  17,-  18,-  21[cp16] 
45(36-47),X,-Y[9],- 2 , -  6 , -  7, -  9 , -  11,-  18,-  19, 
-22[cp18] 
66-69<3n>,X,-Y,add(9)(p22),+mar[cp4] 
63-71<3n>,XXX,+X,del(1)(p21p33),+ , -4 , -  5,+ 8, 
add(9)(p22),+ 10,-  13,+ 14,add(15)(p12),add(15) 
(q21),- 18,+add(19)(q13),add{21)(p21),+ 22,+marl, 
+mar2[cp6] 
51-55<2n>,X,add(Y)(p13),+ del(1)(p22),+ del(2) 
(p15),+ add(3)(p26),+ del(3)(q24),+9,+ 11,+ add 
(14)(q32),hsr(14)(p11),i(17)(p10)x2,add(18)(p11), 
+20,+20, -21 , -  22,-  22,+mar[cp4] 
76(61-95)<3n>,XX,-X,+ 1,  del(1)(p22),+ del(2) 
(p13),+ der(2;3)(ql0;qlO),+ del(3)(q21),-4,add(4) 
(q2?),+ der(4;12)(q10;q10),add(6)(p22),del(7)(q31) 
x2, -  8,der(9)t(9;10)(q34;q22)x2,+hsr(11)(p14), 
- 12,+ 13,der(15)t(1;15)(p22;p13)x3,- 17,+ 20,+ 20, 
+ 20,+r,+marl ,+mar2,+mar3[cp8] 
39---45<2n>,XY,- 19,-  21[cp5] 
o Indicates metaphases that we:~e counted, with markers identified, but which cauld not be completely karyetyped. 
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Table 4 Clinical and histopathologic characteristics of
patients with an adenocarcinoma in the distal 
esophagus without Barrett's mucosa (DO) or 
cardia (C) 
Adenocarcinoma 
Patient 
no. Sex Age pTNM Grade" Localization 
2 M 44 T3NIM1 G3 DO 
6 M 68 T3NIM0 G2 DO 
7 M 46 G2 I' DO 
8 M 44 G2 I' DO 
16 F 62 T3NIM0 G3 DO 
16 M 63 T2NIM1 G3 DO 
28 M 44 T2NOM0 G2 DO 
34 M 54 T3NIM0 G2 DO 
35 M 68 T3NIM0 G3 DO 
37 M 53 T2NIM0 G3 DO 
14 M 69 T3N2M0 G3 C 
21 M 64 T3NIM0 G3 C 
22 M 41 T3NIM0 G3 C 
30 M 63 T3N2M1 G3 C 
33 F 73 T3N2M0 G2 C 
~'Differentiation grade: G1 = well differentiated; G2 = moderately differen- 
tiated; G3 = poorly differentiated. 
1'Tissue sample from a lymph node metastasis. 
by calculating the deoxyribonucleic a id index as defined 
by the convention of nomenclature for deoxyribonucleic 
acid [13]. A diploid histogram contained a G0/G1 peak 
and a G2/tetraploid peak above DNA index 1.90 and 
below DNA index 2.10, with a G2/tetraploid fraction up to 
10%. G2/tetraploid fractions above 10% were considered 
abnormal. An aneuploid population of cells was defined 
as a G0/G1 population of ceils that produced a discrete 
peak separate from the diploid population, constituting 
->5% of the ceils in the biopsy specimens. The coefficient 
of variation was -<6% in all cases. 
Cytogenetics 
Fresh tissue samples of esophageal mucosa and adenocar- 
cinema obtained from the resection specimens were 
minced with sharp scissors into pieces approximately -<1 
mm in diameter. The pieces were incubated in Dulbecco's 
modified Eagles' medium (DMEM)/Ham's F12 culture 
medium containing 5 p,g/mL Amphotericin B, 100 IU/mL 
penicil l in, and 0.2 mg/mL streptomycin for 1 h. The sus- 
pension was washed in medium, then medium containing 
collagenase II (200 IU/mL) was added for several hours to 
obtain enzymatical disaggregation f cells. The suspension 
was washed two times in medium and dispersed into 50-mL 
cell culture T-flasks with 10 mL DMEM/Ham's F12 culture 
medium with 10% fetal calf serum, 0.3 mg/mL glutamine, 
100 IU/mL penicill in, and 0.1 mg/mL streptomycin. The 
cultures were maintained at 37°C in a humidified atmo- 
Table 5 Flow cytometric and cytogenetic analysis of adenocarcinoma in the distal esophagus without Barrett's mucosa 
No. of metaphases analyzed 
Patient Flow cytometry Abnormal Abnormal 
no. (DNA indices) Total Normal nonclonal clonal Karyotype of clonal abnormality 
2 1 1 
6 Aneuploid (1.53) 5 2 3 
7 Aneuploid (1.65) 21 12 + 9" 
8 Diploid 17 10 2 5 
10 Aneuploid (1.56, 1.94) 23 2 5 + 16" 
16 Aneup]oid (1.69) 32 19 2 11 
28 Aneuploid (2.17) 16 12 1 3 
34 8 4 + 4 ~ 
35 Aneuploid (1.73) 1 1 
37 Diploid 1 1 
45(45-64)<2n>,X,-Y[cp31 
63-68<3n>,XXYY, + der(1)t(1;9)(pl2;ql2),+ der(1) 
t(1;9)(p12;q12), + 2,i(3)(q10)x2,add(3)(p26),add(4)(q23), 
-1,-12,der(12)t(10;13)(q23;p12)x2,del(13)(q12),+del, 
(13)(q12), +del(13)(q12), + 14,+ 15,der(16)t(13;16)(q12, 
p13) + der(16)t(13;16)(q12;p13), 17,-18,-19,-20, 
add(21)(q21)x2,- 1,del(22)(p11)x2,der(22)t(3;22)(p12, 
p13),+der(22)t(3;22)(p12;p13),+r,+mar [cp21] 
91-94<4n>,XXYY, + 12, + 18[cp5] 
50-64<2n>,XX,add(1)(p33), + add(1)(q43),+ 2,del(3) 
(p14), +i(3)(q10),del(4)(p12),- 4,add(5)(q35), + 5,add 
(6)(p23),del(7)(q31),+ der(7;11)(pl0;ql0),del(8)(p21), 
del(11)(p14),add(11)(p15), + hsr(12)(p12),add(13)(p11), 
- 13,i(14)(q10),add(15)(q26), + 16,de1(17)(q25), +add 
(17)(p12),+20,+20,+21,+21,add(22)(p12),+mar[cp211 
40(28-45)<2n>,X,-Y[5],- 1 , -2 , -4 , -5 , -9 , -  11,- 13, 
-17, 18,-22[cp11] 
44-45,X,-Y[cp3] 
58-60<3n>,XX,-Y,add(1)(p11),del(3)(p24),+ del(3) 
(p24),-4,i(5)(p10),- 6 add(7)(pl ?),add(8)(q24)x2,add 
(9)(p21),-9,hsr(11)(p14),del(12)(q21), 12 i(14)(q10), 
- 14,- 15,- 17,- 17,- 18,- 18,- 18,-21,-21,+r, 
+4mar[cp8] 
"Indicates metaphases that were counted, with markers identified, but which could not be completely karyotyped. 
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Table 6 Flow cytometric and cytogenetic analysis of adenocarcinoma in the cardia 
No. of metaphases analyzed 
Patient Flow cytometry Abnormal Abnormal 
no. (DNAindices) Total Normal nonclonal clonal Karyotype ofclonal abnormality 
14 6 6 
21 Tetraploid 1 1 
22 Aneuploid 1 1 
(1.41, 2.69) 
30 6 5 1 
33 11 2 9 60-77<3n>,XX,-X,- 1,add(3)(q29),+i(3)(q10),- 4,- 5,del(6)(q24)x2, 
+ add(6)(p22),add(8)(p22),- 1 ,add(13)(q34),+add(13)(q34),add(14) 
(q32)x2,- 14,add(15)(p13),- 15,+ 16,+ 16,+ 16,+ 16,add(17)(q25), 
del(17)(q22),- 18,add(20)(p11),- 20,- 21,- 22,+mar[cp9] 
sphere of 5% carbon dioxide in air. The specimens were 
harvested for cytogenetic analysis after 2 or 3 days of growth 
in vitro (short-term culture). To synchronize the cells in 
the cell cycles the cultures were treated with methotrexate 
(1 p.g/mL) overnight and tymidine (10 ~ M) 6 h before har- 
vesting [14]. Metaphase cells were arrested by exposure to 
colcemid (0.1 ixg/mL) for l h. The mitotic cells were loos- 
ened by shaking the culture flasks, washed with medium, 
swelled in KC1 0.075 M at 37°C for 8 min, and fixed 
according to standard pr,3cedures using methanol:acetic 
acid (3:1). The remaining monolayer was flooded with 
KC1-EGTA for 20 min and scraped out with a rubber 
policeman, washed with KC1 0.075 M, and processed as 
above. The chromosomes were identified using RFA and 
QFQ banding. The quality of metaphases was irregular, 
and not all cells could always be fully karyotyped. Karyo- 
type designations were in accordance with the Interna- 
tional System for Human Cytogenetic Nomenclature [15]. 
As a control, preoperative blood samples of the patients 
were obtained and cytogenetic analysis of the leucocytes 
was performed. 
RESULTS 
Clinical Characteristics 
Table 1 shows the clinicm and histopathologic characteris- 
tics of 22 patients with an adenocarcinoma in Barrett's 
esophagus. The histologic diagnosis of the mucosal speci- 
mens on which cytogenetic and FCM analysis were per- 
formed are listed according to the mucosal type (i.e., 
Barrett's epithelium or squamous epithelium). In one 
patient (no. 19), tumor tissue for cytogenetic analysis was 
obtained from a lymph node metastasis, while the tissue 
culture of the primary tumor was not successful. 
Barrett's Mucosa 
The results of flowcytometric (12 cases) and cytogenetic 
analysis (eight cases) of Barrett's mucosa are listed in 
Table 2. FCM showed aneuploidy in three cases, of which 
clonal abnormalities were found in one (no. 25). In this 
patient he DNA index of Barrett's mucosa was 1.61, corre- 
lating with the modal chromosome number (near triploid) 
found at cytogenetic analysis. One of the diploid speci- 
mens of Barrett's mucosa showed a hypodiploid karyotype 
with loss of the Y chromosome. The number of meta- 
phases was insufficient in four cases (fewer than five mito- 
ses). In three patients the mucosal tissue samples that 
were analyzed cytogenetically contained only squamous 
epithelium. In these cases Barrett's mucosa seen histologi- 
cally in their resection specimens was not present in the 
tissue samples for cytogenetic analysis. These samples all 
showed normal karyotypes. In 11 patients of 22, tissue 
cultures of the mucosa were not successful, which pre- 
vented cytogenetic analysis. 
Adenocarcinoma 
Table 3 lists the data of flow cytometric and cytogenetic 
analysis of 22 adenocarcinomas in Barrett's esophagus. 
FCM showed aneuploidy in 14 cases, of which the DNA 
indices varied between 1.42 and 1.72 in 10 cases. Four of 
these 10 tumors also showed near-triploid karyotypes 
(nos. 19, 25, 31, and 36). Patient 13 exhibited two distinct 
clonal populations, one hypodiploid and another near 
triploid, both showing the same markers. Of the 12 cytoge- 
netic abnormal clones identified, five were hypodiploid 
and two of these corresponded to near-triploid FCM indi- 
ces, a situation similar to that of patient 13. There were no 
Figure I Histogram of flow cytometric analysis of tumor tissue 
of patient no. 7, 
no. of events 
I I 
DNA-Content 
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Figure 2 Histogram of all clonal numerical chromosome changes observed in tumor cells of 19 patients with an 
adenocarcinoma in Barrett's esophagus (11), the distal esophagus without Barrett's mucosa (7), and cardia (1). 
Gains and losses depicted are determined relative to ploidy. Unidentified markers are also shown, r = ring chromo- 
some, dm = double minute, mar = marker chromosome. 
mitoses found in one case, and an inadequate number of 
metaphases in four cases. In four tumors aneuploidy or 
tetraploidy was found by FCM, but this could not be con- 
firmed cytogenetically. 
Table 4 shows the clinical and histopathologic charac- 
teristics of the patients with an adenocarcinoma in the dis- 
tal esophagus without Barretrs mucosa (n = 10) and 
cardia (n -- 5). In two patients the tumor appeared to be ir- 
resectable at laparotomy and tumor tissue was obtained 
from lymph node metastases (nos. 7 and 8). All esophageal 
mucosa specimens were of the squamous cell type. Cyto- 
genetic analysis of squamous epithel ium was performed 
in six cases, and at random, numeric changes were found 
in four of them. In the other nine patients tissue cultures 
of the squamous epithel ium were not successful. 
The results of FCM and cytogenetic analysis of adeno- 
carcinoma located in the distal esophagus without Bar- 
rett's mucosa and cardia are l isted in Tables 5 and 6, 
respectively. FCM showed aneuploidy in six of the 10 ade- 
nocarcinomas of the distal esophagus, of which the DNA 
index correlated with the modal chromosome number 
found at cytogenetic analysis in two (nos. 7 and 10) (Table 
5). An FCM histogram of patient 7 showed a hypodip lo id 
shoulder and an aneuploid peak with a DNA index of 1.65 
(Fig. 1). Furthermore, three others had DNA indices vary- 
ing between 1.53 and 2.17, but hypodip lo id cytogenetic 
clones were found (nos. 6, 16, and 28). An inadequate 
number of metaphases was found in three cases. FCM 
showed a tetraploid population in one case and aneu- 
ploidy in another case of adenocarcinoma of the cardia 
(Table 6). In both cases only one metaphase was analyzed 
and showed a normal karyotype. More than 10 metaphases 
were analyzed in one case, in which an abnormal clone 
was found. Constitutional chromosomal abnormalit ies 
were not found in any of the patients by cytogenetic analy- 
sis of peripheral blood lymphocytes. 
Clonal chromosomal abnormalit ies in Barrett's mucosa 
were seen in two cases with near-diploid and near-triploid 
chromosome numbers, respectively. In 19 cases clonal 
chromosomal abnormalit ies were found in tumor tissue. 
These were analyzed for the presence of common numeric 
and structural aberrations. All chromosomes contributed 
to numeric changes. Gains and losses of chromosomes, de- 
termined relatively to ploidy, were plotted on a histogram 
(Fig. 2). When compared with the ploidy of individual  tu- 
mors, whole chromosome losses were more  common than 
gains. Losses of chromosomes 4, 18, 21, and Y were the 
most frequent numeric losses. Loss of the Y was observed 
in eight of 13 tumors of males (62%). Chromosomes 14 
and 20 were most frequently gained. Loss of chromosome 
16 was not observed. Structural abnormalit ies were ob- 
served in 13 of the abnormal clonal karyotypes (68%). All  
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Figure 3 Histogram of all clonal structural chromosome changes observed in tumor cells of 12 patients with an 
adenocarcinoma in Barrett's esophagus (8), the distal esophagus without Barrett's mucosa (3), and cardia (1). Diag- 
onal bars = isochromosomes; hatched bars, unbalanced translocations). 
chromosome arms except lOp, 16q, 18q, 19p, 20q, and 
chromosome X participated in structural changes (Fig. 3). 
The chromosome arms most frequently rearranged were 
lp, 3q, 11p, and 22p. Abnormalities of chromosome lp 
arm frequently resulted in (partial) deletion, with the 
shortest region of overlap at lp22-33 (Fig. 4). In contrast, 
chromosome 11p and 22p rearrangements often showed 
gain of material. A homogenous taining region (hsr) of 
11p14 was observed in three cases and gain at 11p15 in 
one case, whereas a deletion on chromosome arm 11p was 
seen in one case with th~ break point at 11p14 (Fig. 4). 
Structural rearrangements of chromosome arm 3q were 
frequently observed, including deletions in two cases, 
gains in two cases, an unbalanced transtocation in one 
case, and isochromosomes in three cases (Fig. 4). The 
breakpoint occurred at the centromere in four cases. Sev- 
eral recurrent isochromosomes were identified. The most 
frequent were i(3q) in three cases, i(13q) in two cases, and 
i(14q) in two cases. 
DISCUSSION 
In 1976 Nowell hypothesized that cancer develops in asso- 
ciation with an acquired genetic instability that predis- 
poses to the acquisition of abnormal clones of cells with 
accumulated genetic errors [16]. It has been demonstrated 
that neoplastic progression in Barrett's esophagus i  asso- 
ciated with a similar process of clonal evolution [5, 6, 10, 
17]. In our study we analyzed 37 adenocarcinomas of the 
esophagus and cardia, of which 22 arose in Barrett's 
esophagus. In Barrett's mucosa we found normal karyo- 
types, except in one case where a complex karyotype was 
found with the same markers and rearrangements as in the 
adenocarcinoma of the same patient. A theoretical possi- 
bility in this case is that the abnormal tissue obtained from 
the Barrett's egment hat was spatially separate from the 
cancer contained an unidentified microscopic focus of car- 
cinoma. A specific karyotypic hange common to all cases 
with genetic abnormalities was not found. The absence of 
differences in the complex pattern of cytogenetic changes 
between adenocarcinomas in Barrett's esophagus, the dis- 
tal esophagus without Barrett's mucosa or cardia, suggests 
a common pathway of origin at all three anatomic sites. 
This is similar to the results of others [8, 9]. A good corre- 
lation between DNA indices of the aneuploid tumors and 
the modal chromosome numbers of the abnormal karyo- 
types was found in most of the tumors with multiple and 
complex chromosomal rearrangements. Recurrent combi- 
nation of hypodiploid and triploid clones correspond to a 
pattern of clonal progression that is characterized by chro- 
mosome losses followed by secondary duplication and 
losses, a mechanism which has previously been described 
in adenocarcinoma [18]. Whereas balanced translocations 
were seldom found in this study, losses due to missing 
chromosomes or apparently unbalanced rearrangements 
(derivative chromosomes, deletions, and isochromosomes) 
were frequently observed. Marker chromosomes were 
common and some of the missing chromosomal material 
obviously resides in these unidentified chromosomes. 
Whole chromosome losses of 4, 18, and 21, and in males, 
Y, were the most frequent numeric changes in this series. 
Frequent numeric loss of chromosomes 4, 18, 21, and Y 
has been described in colorectal carcinoma [19-22]. Loss 
of the Y chromosome has been demonstrated in different 
gastrointestinal malignancies [19, 20, 23] and brain tumors 
[22, 24]. In Barretrs esophagus and esophageal adenocar- 
cinoma loss of the Y chromosome also appears to be a 
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Figure 4 Examples of rearrangements affecting chromosome arms lp, 3q, and 11p in the tumors tudied, Patient 
numbers are indicated under the rearranged chromosomes. R bands are used in the majority of cases and Q bands 
for patient nos. 1 (chromosome 11), 5 (chromosome 1}, 31 (chromosomes 1 and 3), and 36 (chromosome 3). 
common occurrence [7, 8, 17, 25]. It has been suggested 
that tissues retaining rapid cellular proliferation rates in 
elderly men are more prone to loss of the Y chromosome 
[26]. In our series loss of the Y chromosome in Barrett's 
mucosa and adenocarcinoma occurred in 62% of the male 
patients, but not merely the oldest ones. Furthermore, 
cytogenetic analysis of peripheral blood lymphocytes did 
not reveal Y loss. Although there is a male predominance 
in the incidence of Barrett's esophagus and esophageal 
adenocarcinoma [1, 4, 27], the significance of Y loss in 
unclear, because there are no cancer genes l inked to the Y 
chromosome so far. Recurrent gains of chromosomes 14 
and 20 were seen in this series. Extra copies of chromo- 
some 20 were also found in colorectal carcinomas [19, 22]. 
Structural abnormalit ies of chromosome arms lp,  3q, 11p, 
and 22p were most frequently observed. Structural rear- 
rangements of the short arm of chromosome 1 resulted 
most often in deletions, with the shortest region of overlap 
being lp22-33.  Frequent rearrangements of chromosome 
arm lp  were also described in gastric and colorectal carci- 
nomas [20, 23]. N-ras, a transforming ene from a neuro- 
blastoma cell line, has been assigned to lp22-31 [28, 29l. 
Rao et al. described structural rearrangements of 3q in six 
of nine gastric and esophageal adenocarcinomas [9]. 
Al lelotype analysis in osteosarcomas suggests the exist- 
ence of tumor suppressor genes on the long arm of chro- 
mosome 3 [30]. Structural rearrangements in the 11p13-15 
region were found in Barrett's adenocarcinomas nd other 
adenocarcinomas of the esophagus and stomach [8]. 
Genetic changes affecting the 1 lp13-15 region have previ- 
ously been associated with Wilm's tumor, hepatoblastoma, 
rhabdomyosarcoma, and carcinoma of the bladder and 
breast [31-33]. Furthermore, the H-ras-1 protooncogene 
has been localized to band 11p15 [33]. Whether these can- 
cer genes are implicated in the progression of oesophageal 
tumors should be investigated using molecular tech- 
niques. 
These studies show that Barrett's mucosa and adeno- 
carcinoma can be successfully karyotyped using banding 
techniques. A chromosomal abnormality common to all 
tumors was not identified, although hot spots for struc- 
tural rearrangements have been seen in chromosomes lp,  
3q, 11p, and 22p, as well as frequent losses of chromo- 
somes 4, 18, 21, and Y. 
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